DaShenLin Pharmaceutical Group. (603233.SHG) Q4 2024 Earnings

Oct 31Confirmed
Oct 2022
Q2 2024
Q3 2024
Q4 2024
0.18
0.25
0.32
0.39

Details

Expected EPS
0.24060741170129996
Actual EPS
0.18055925793864
Surprise EPS
-0.06
Surprise Percent
-24.96%

Description

⁨DaShenLin Pharmaceutical Group.⁩ (⁦603233.SHG⁩) has reported earnings of ⁦0.18055925793864⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts